SCOPUS 정보 검색 플랫폼

The Lancet

Volumn 385, Issue 9986, 2015, Pages 2443-2445

Towards interferon-free treatment for all HCV genotypes

(1) Wedemeyer, Heiner a

a HANNOVER MEDICAL SCHOOL (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DACLATASVIR; DASABUVIR; LEDIPASVIR; LEDIPASVIR PLUS SOFOSBUVIR; OMBITASVIR; OMBITASVIR PLUS PARITAPREVIR PLUS RITONAVIR; PARITAPREVIR; RIBAVIRIN; SIMEPREVIR; SOFOSBUVIR; ANILIDE; CARBAMIC ACID DERIVATIVE; MACROCYCLIC COMPOUND; RITONAVIR;

ANTIVIRAL THERAPY; DRUG APPROVAL; EUROPEAN MEDICINES AGENCY; FOOD AND DRUG ADMINISTRATION; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; FEMALE; GENETICS; HEPACIVIRUS; HEPATITIS C, CHRONIC; MALE;

ANILIDES; CARBAMATES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MACROCYCLIC COMPOUNDS; MALE; RIBAVIRIN; RITONAVIR;

EID: 84931575697 PISSN: 01406736 EISSN: 1474547X Source Type: Journal
DOI: 10.1016/S0140-6736(15)60605-5 Document Type: Note

Times cited : (16)

References (12)

1
- 84931070109
- Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting
- published online Dec 30
- C Höner zu Siederdissen, B Maasoumy, K Deterding et al. Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting Liver Int 2014 10.1111/liv.12774 published online Dec 30.
- (2014) Liver Int
- Höner Zu Siederdissen, C.¹ Maasoumy, B.² Deterding, K.³

2
- 84925649961
- Hepatitis C
- published online Feb 13
- DP Webster, P Klenerman, GM Dusheiko Hepatitis C Lancet 2015 published online Feb 13. http://dx.doi.org/10.1016/S0140-6736(14)62401-6
- (2015) Lancet
- Webster, D.P.¹ Klenerman, P.² Dusheiko, G.M.³

3
- 0345188811
- Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
- V Lohmann, F Körner, J Koch, U Herian, L Theilmann, R Bartenschlager Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line Science 285 1999 110 113
- (1999) Science , vol.285 , pp. 110-113
- Lohmann, V.¹ Körner, F.² Koch, J.³ Herian, U.⁴ Theilmann, L.⁵ Bartenschlager, R.⁶

4
- 84921060015
- Global distribution and prevalence of hepatitis C virus genotypes
- JP Messina, I Humphreys, A Flaxman et al. Global distribution and prevalence of hepatitis C virus genotypes Hepatology 61 2015 77 87
- (2015) Hepatology , vol.61 , pp. 77-87
- Messina, J.P.¹ Humphreys, I.² Flaxman, A.³

5
- 84914150658
- Global epidemiology and genotype distribution of the hepatitis C virus infection
- E Gower, C Estes, S Blach, K Razavi-Shearer, H Razavi Global epidemiology and genotype distribution of the hepatitis C virus infection J Hepatol 61 2014 S45 S57
- (2014) J Hepatol , vol.61 , pp. S45-S57
- Gower, E.¹ Estes, C.² Blach, S.³ Razavi-Shearer, K.⁴ Razavi, H.⁵

6
- 84920969787
- Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: A validated model using objective and readily available clinical parameters
- AJ van der Meer, BE Hansen, G Fattovich et al. Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters Gut 64 2015 322 331
- (2015) Gut , vol.64 , pp. 322-331
- Van Der Meer, A.J.¹ Hansen, B.E.² Fattovich, G.³

7
- 84913592791
- Natural history of hepatitis C
- RH Westbrook, G Dusheiko Natural history of hepatitis C J Hepatol 61 2014 S58 S68
- (2014) J Hepatol , vol.61 , pp. S58-S68
- Westbrook, R.H.¹ Dusheiko, G.²

8
- 84927796279
- Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry
- published online Nov 5
- PJ Ruane, D Ain, R Stryker et al. Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry J Hepatol 2014 10.1016/j.jhep.2014.10.044 published online Nov 5.
- (2014) J Hepatol
- Ruane, P.J.¹ Ain, D.² Stryker, R.³

9
- 84931569160
- Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): A randomised, open-label trial
- published online March 31
- C Hézode, T Asselah, KR Reddy et al. Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial Lancet 2015 published online March 31. http://dx.doi.org/10.1016/S0140-6736(15)60159-3
- (2015) Lancet
- Hézode, C.¹ Asselah, T.² Reddy, K.R.³

10
- 84893701238
- The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C
- B Maasoumy, K Port, B Calle Serrano et al. The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C Aliment Pharmacol Ther 38 2013 1365 1372
- (2013) Aliment Pharmacol Ther , vol.38 , pp. 1365-1372
- Maasoumy, B.¹ Port, K.² Calle Serrano, B.³

11
- 84920265713
- Estimates on HCV disease burden worldwide - Filling the gaps
- H Wedemeyer, GJ Dore, JW Ward Estimates on HCV disease burden worldwide - filling the gaps J Viral Hepat 22 2015 1 5
- (2015) J Viral Hepat , vol.22 , pp. 1-5
- Wedemeyer, H.¹ Dore, G.J.² Ward, J.W.³

12
- 84902129061
- Strategies to manage hepatitis C virus (HCV) disease burden
- H Wedemeyer, AS Duberg, M Buti et al. Strategies to manage hepatitis C virus (HCV) disease burden J Viral Hepat 21 2014 60 89
- (2014) J Viral Hepat , vol.21 , pp. 60-89
- Wedemeyer, H.¹ Duberg, A.S.² Buti, M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.